Neurovascular Regulation During Exercise in Humans With Chronic Kidney Disease: Sympatholysis in CKD

PHASE2RecruitingINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

November 11, 2022

Primary Completion Date

June 1, 2028

Study Completion Date

June 1, 2028

Conditions
Chronic Kidney Disease
Interventions
DRUG

Sodium Bicarbonate

Participants take 650-1300 mg of sodium bicarbonate orally twice daily. Serum bicarbonate levels are measured at baseline and then every 2-4 weeks throughout the trial. Doses will be adjusted or held to avoid metabolic alkalosis.

BEHAVIORAL

Exercise Training

"Exercise training consists of progressive, interval-based Spin exercise on stationary bicycles three times per week for 12 weeks, led by a certified exercise physiologist. The duration of each session begins at 20 minutes and is increased by 1 to 2 minutes as tolerated to a goal of 45 minutes per session. Exercise intensity begins at low levels (50% of maximal heart rate reserve (HRR)) and increases by 5% every week to a goal of 75% maximal HRR. Each session includes a 5-min warm up, then an interval-based, work-out phase that includes steady up-tempo cadences, sprints, and climbs, followed by a 5-minute cool down."

DRUG

Placebo

Participants take placebo pills to match 650-1300 mg of sodium bicarbonate orally twice daily.

Trial Locations (2)

30033

RECRUITING

Atlanta VA Medical Center, Decatur

30322

RECRUITING

Emory Clinic, Atlanta

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Emory University

OTHER